Why is Astec Lifescienc falling/rising?

As of 29-Aug, Astec Lifesciences Ltd is experiencing a price increase, currently at Rs 879.30, reflecting a rise of 18.85 (2.19%). The stock has shown a positive performance today, outperforming its sector by 2.02% and achieving a consecutive gain over the last two days with a total return of 3.08%. Despite this short-term uptick, the stock has faced significant challenges, including a year-to-date decline of 12.51% and a staggering 53.72% drop over the past three years. The company has reported operating losses for the last five consecutive quarters, with a negative EBITDA and a high Debt to EBITDA ratio of 2.64 times, indicating weak long-term fundamental strength and low profitability.
Broader market context reveals that while Astec Lifesciences has outperformed the sector in the short term, its overall performance remains concerning when compared to the benchmark. The Sensex has shown a slight increase of 2.14% year-to-date, contrasting sharply with Astec's significant declines. The stock's recent gains may be attributed to short-term trading dynamics, as it is currently trading above its moving averages; however, the falling investor participation and consistent underperformance against the benchmark over the last three years suggest that the stock's long-term outlook remains precarious.